SB
White House trade
Sara Bailey bought $1K-$15K of Byrna Technologies Inc. (BYRN) stock
Sara Bailey, Director, Office of National Drug Control Policy, disclosed a purchase of Byrna Technologies Inc. (BYRN) stock worth $1K-$15K in an OGE Form 278-T released Jun 11, 2026.
The trade happened on Mar 1, 2026, 102 days before it was made public.
BYRN has moved -72.8% since the trade date, from $12.78 to $3.48 (Oct 1, 2026 close).
- Traded
- Mar 1, 2026
- Disclosed
- Jun 11, 2026
- Filing delay
- 102 days
- Price since
- -72.8%
- Source
- OGE Form 278-T
Other trades in this filing (2)
More BYRN insider and Congress trades
From a public OGE Form 278-T, linked above. Not investment advice, and not a recommendation to buy or sell.